News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
Partners

Robert Dreicer, MD

Articles by Robert Dreicer, MD

Predicting Immunotherapy Response in Bladder Cancer

ByRobert Dreicer, MD

March 21st 2019

PD-L1 status may not be the best predictor when it comes to determining who will respond to checkpoint blockade.

Latest Updated Articles

Predicting Immunotherapy Response in Bladder Cancer
Published: March 21st 2019 | Updated:

Trending on Oncology Nursing News

Understanding and Managing Chemo-Induced Myelosuppression as an APP

Niraparib/Abiraterone Acetate Combo Maintains Baseline HR-QOL in HRRM+ mHSPC

© 2025 MJH Life Sciences^®

All rights reserved.